As of 2025-07-02, the Intrinsic Value of Fisher & Paykel Healthcare Corporation Ltd (FPH.NZ) is 15.60 NZD. This FPH.NZ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 37.42 NZD, the upside of Fisher & Paykel Healthcare Corporation Ltd is -58.30%.
The range of the Intrinsic Value is 10.24 - 35.32 NZD
Based on its market price of 37.42 NZD and our intrinsic valuation, Fisher & Paykel Healthcare Corporation Ltd (FPH.NZ) is overvalued by 58.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 10.24 - 35.32 | 15.60 | -58.3% |
| DCF (Growth 10y) | 13.46 - 46.09 | 20.50 | -45.2% |
| DCF (EBITDA 5y) | 26.02 - 40.59 | 29.60 | -20.9% |
| DCF (EBITDA 10y) | 27.57 - 50.47 | 34.18 | -8.6% |
| Fair Value | 16.09 - 16.09 | 16.09 | -57.01% |
| P/E | 14.48 - 21.00 | 16.87 | -54.9% |
| EV/EBITDA | 15.17 - 20.79 | 17.18 | -54.1% |
| EPV | 1.49 - 2.32 | 1.91 | -94.9% |
| DDM - Stable | 4.78 - 22.53 | 13.66 | -63.5% |
| DDM - Multi | 9.62 - 34.42 | 14.95 | -60.0% |
| Market Cap (mil) | 21,937.85 |
| Beta | 1.20 |
| Outstanding shares (mil) | 586.26 |
| Enterprise Value (mil) | 21,826.65 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.99% |
| Cost of Debt | 5.50% |
| WACC | 9.95% |